anx_II__para_3__continuation__11
91/666/EEC: Council Decision of 11 December 1991 establishing Community reserves of foot-and-mouth disease vaccines · European Union
In consultation with, and under the supervision of, the CCI, the producer must also provide 20 representative samples containing at least 1 mg each of concentrated 146S antigen for periodic in vitro and in vivo tests; and
← anx_II__para_3__continuation__10 · All articles · anx_II__para_3__continuation__12 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-08 · Text as adopted (Official Journal); later amendments are not incorporated in this text.